CIC
LH icon

Carnegie Investment Counsel’s Labcorp LH Stock Holding History

Carnegie Investment Counsel’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$356K Buy
1,333
+94
+8% +$25.5K 0.01% 456
2025
Q4 		$311K Sell
1,239
-400
-24% -$106K 0.01% 476
2025
Q3 		$470K Hold
1,639
– – 0.01% 414
2025
Q2 		$430K Sell
1,639
-28
-2% -$6.82K 0.01% 414
2025
Q1 		$373K Buy
1,667
+34
+2% +$8.25K 0.01% 408
2024
Q4 		$374K Hold
1,633
– – 0.01% 377
2024
Q3 		$365K Hold
1,633
– – 0.01% 376
2024
Q2 		$332K Hold
1,633
– – 0.01% 391
2024
Q1 		$357K Hold
1,633
– – 0.01% 403
2023
Q4 		$371K Sell
1,633
-10
-0.6% -$2.1K 0.01% 388
2023
Q3 		$330K Sell
1,643
-269
-14% -$56.7K 0.01% 396
2023
Q2 		$397K Sell
1,912
-32
-2% -$6.21K 0.01% 382
2023
Q1 		$383K Sell
1,944
-29
-1% -$5.97K 0.02% 388
2022
Q4 		$399K Hold
1,973
– – 0.02% 392
2022
Q3 		$347K Hold
1,973
– – 0.02% 383
2022
Q2 		$397K Hold
1,973
– – 0.02% 365
2022
Q1 		$447K Hold
1,973
– – 0.02% 360
2021
Q4 		$533K Sell
1,973
-349
-15% -$86.4K 0.02% 344
2021
Q3 		$561K Hold
2,322
– – 0.02% 308
2021
Q2 		$550K Sell
2,322
-134
-5% -$30.5K 0.02% 317
2021
Q1 		$538K Buy
2,456
+693
+39% +$139K 0.02% 311
2020
Q4 		$308K Sell
1,763
-68
-4% -$11.7K 0.01% 359
2020
Q3 		$296K Buy
1,831
+143
+8% +$22.7K 0.02% 343
2020
Q2 		$241K Buy
+1,688
New +$234K 0.01% 372
2020
Q1 		– Sell
-1,571
Closed -$228K – 415
2019
Q4 		$228K Hold
1,571
– – 0.01% 390
2019
Q3 		$227K Hold
1,571
– – 0.01% 393
2019
Q2 		$233K Sell
1,571
-88
-5% -$12.3K 0.02% 394
2019
Q1 		$218K Buy
+1,659
New +$204K 0.02% 396
2018
Q4 		– Sell
-1,659
Closed -$234K – 388
2018
Q3 		$234K Sell
1,659
-116
-7% -$17.6K 0.02% 320
2018
Q2 		$275K Sell
1,775
-437
-20% -$66K 0.02% 330
2018
Q1 		$334K Hold
2,212
– – 0.03% 293
2017
Q4 		$322K Hold
2,212
– – 0.03% 317
2017
Q3 		$288K Hold
2,212
– – 0.03% 295
2017
Q2 		$304K Sell
2,212
-291
-12% -$35.6K 0.04% 293
2017
Q1 		$305K Hold
2,503
– – 0.04% 286
2016
Q4 		$278K Buy
2,503
+117
+5% +$13K 0.04% 276
2016
Q3 		$279K Hold
2,386
– – 0.04% 263
2016
Q2 		$282K Hold
2,386
– – 0.04% 267
2016
Q1 		$240K Hold
2,386
– – 0.04% 272
2015
Q4 		$230K Sell
2,386
-117
-5% -$12.1K 0.04% 262
2015
Q3 		$259K Hold
2,503
– – 0.04% 250
2015
Q2 		$261K Hold
2,503
– – 0.05% 250
2015
Q1 		$268K Hold
2,503
– – 0.05% 251
2014
Q4 		$248K Buy
2,503
+175
+8% +$15.5K 0.05% 251
2014
Q3 		$204K Sell
2,328
-87
-4% -$7.86K 0.04% 281
2014
Q2 		$212K Hold
2,415
– – 0.05% 220
2014
Q1 		$204K Buy
+2,415
New +$193K 0.05% 207
2013
Q4 		– Sell
-2,415
Closed -$206K – 213
2013
Q3 		$206K Hold
2,415
– – 0.06% 197
2013
Q2 		$208K Buy
+2,415
New +$200K 0.07% 186

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Carnegie Investment Counsel's LH Position: Q1 2026 in Review

Carnegie Investment Counsel increased its Labcorp (LH) stake by 7.6% in Q1 2026, buying an estimated $25.5K and bringing the position to 1,333 shares worth $356K. The position accounts for 0.01% of the portfolio, ranked #456.

Carnegie Investment Counsel first reported a position in LH in Q2 2013 and has held it in 49 quarters since. The position peaked at $561K in Q3 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Carnegie Investment Counsel held 1,333 shares of Labcorp worth $356K as of Q1 2026.
  • Carnegie Investment Counsel bought 94 Labcorp shares in Q1 2026, an estimated $25.5K.
  • Labcorp made up 0.01% of Carnegie Investment Counsel's portfolio in Q1 2026, its #456 holding.
  • Carnegie Investment Counsel first reported a position in Labcorp in Q2 2013 and has held it in 49 quarters since.
  • Carnegie Investment Counsel's Labcorp position peaked at $561K in Q3 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Carnegie Investment Counsel's 13F filing for Q1 2026, filed 1 May 2026.